Hoffner, Guylaine <br/><br/>
Polyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?  [electronic resource] 

 -  Molecular neurobiology  Dec 2015 
 - 1297-1314 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1559-1182 
<br/><br/><label>Standard No.: </label>10.1007/s12035-014-8932-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloid--chemistry<br/>Animals<br/>Animals, Genetically Modified<br/>Birefringence<br/>Brain--ultrastructure<br/>Epitopes--chemistry<br/>Humans<br/>Huntingtin Protein<br/>Huntington Disease--metabolism<br/>Inclusion Bodies<br/>Mice<br/>Models, Molecular<br/>Nerve Tissue Proteins--chemistry<br/>Peptide Fragments--chemistry<br/>Peptide Hydrolases--metabolism<br/>Peptides--immunology<br/>Polymerization<br/>Protein Aggregates--physiology<br/>Protein Aggregation, Pathological--metabolism<br/>Protein Folding<br/>Protein Structure, Secondary<br/>Protein Transport<br/>Rats<br/>Solubility<br/>Structure-Activity Relationship<br/>X-Ray Diffraction